Medical Mktg Share Discussion Threads

[binladin] 20/4/2009 08:57

back to under 4p.

[el magnifico] 02/4/2009 19:17

Benny,

I bought on the (current)bid last week.

Nice, but hard to see it as a positive, since share prices tend go higher when the offer is taken out, not when you can buy at the bid price.

Still, I bought more for the technology platform , not the "momentum", so I shouldn't worry.

Would be nice to see some good news before the piggy bank runs out.

el

[bennytheball] 31/3/2009 15:43

You sure they're all sells?
b

[tenapen] 31/3/2009 15:33

The share price is holding up well Benny, near constant selling and yet the MMs have not dropped the price.
I sold after the MW update. I do not subscribe to his site but i felt that if Mike could not generate any buys with his up-date then there realy is no enthusiasm for the shares.
Hope to buy back when / if news comes.

regards.

[bennytheball] 31/3/2009 12:48

Interesting - 200k traded yesterday and no price movement?!
It's eerily quiet around here.
b

[bennytheball] 25/3/2009 11:17

Just looked up the details again - it's only a poster presentation so presumably it will be for the whole conference, although I'm not sure it will be a significant event in itself.
And the display may just present information already out there...
b

[sleepinggiant] 25/3/2009 10:56

18th-22nd April....im sure we will know nearer date waht time day MMG will be presenting...

[bennytheball] 25/3/2009 08:28

sleepinggiant, what date's the Denver presentation?

[sleepinggiant] 23/3/2009 10:14

There will be Benny the 1st 2 weeks of April as we near the Ruthenium presentation in Denver....half decent and who knows the yanks hopefully will want to get involved...would expect t+20 trades coming in any day now on hope hope hope....

[bennytheball] 23/3/2009 09:34

One week until the end of Q1.
Volume trailed off again and all gone very quiet.
I'd have imagined a bit more excitement and anticipation...

[pamskie2] 13/3/2009 11:17

Thanks for that BtB

[bennytheball] 13/3/2009 10:56

Google News Alert for: "medical marketing international"



Business Weekly - UK

[tenapen] 06/3/2009 20:09

I wonder where the share price would have been at the close of play today if we had not got the RNS up-date :-/.
If a MW up-date can not generate interest in buying the shares no wonder we are getting some selling coming through.

[bennytheball] 05/3/2009 07:06

The volume is building nicely - been at least 100k traded every day for a couple of weeks, with two days 400-500k.

[mitzis] 04/3/2009 22:07

From a chart perspective its a Buy for the last 2 weeks but is it worth chasing I dont know.

[everton448] 04/3/2009 21:35

New write up from Mike Walters i believe (I'm not a subscriber)

[jakes114] 04/3/2009 16:14

Not a very inspiring news release, who have they got writing them, not very informative certainly lacks detail how is anyone supposed to make a valuation or prospect with this bland staement

[tenapen] 04/3/2009 09:38

I like neutral and the management are correct to be giving over that impression to save Joe public buying in and possibly, depending how the future pans out loose money. But if this is it for news in the coming months !.

[everton448] 04/3/2009 09:31

Fair point tenapen. What's interesting is what seems tio be the deliberate attempt on the part of the current management to present everything neutrally - unlike the previous regime where the enthusiasm was plain to see.

[tenapen] 04/3/2009 09:26

Progress, but not enough for the time span and the money spent !.

I don't know.

[everton448] 04/3/2009 09:21

From the interims

"A commercial prostate cancer vaccine ("GVX 3322") has been assembled and the DNA sequence verified. GVX 3322 is now undergoing
preclinical equivalence studies with the academic vaccine used in the current clinical trial. The in vivo immunogenicity studies are
on-going and will now complete in the first quarter of 2009. If a positive result is obtained, the Company will continue its preparations
for the commencement of a Phase II trial."


From the update

"The commercial prostate cancer vaccine ("GVX 3322") has completed the
preclinical equivalence studies with the academic vaccine being used in the
current clinical trial. The positive result obtained in this study allows the
Company to continue its preparations for the commencement of a Phase II trial."

Progress!